Zevin Asset Management LLC decreased its stake in shares of HCP, Inc. (NYSE:HCP) by 1.8% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 108,342 shares of the real estate investment trust’s stock after selling 1,979 shares during the period. HCP comprises about 1.2% of Zevin Asset Management LLC’s investment portfolio, making the stock its 29th biggest holding. Zevin Asset Management LLC’s holdings in HCP were worth $3,860,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of HCP. Lenox Wealth Management Inc. lifted its holdings in HCP by 2,026.8% in the third quarter. Lenox Wealth Management Inc. now owns 7,763 shares of the real estate investment trust’s stock worth $276,000 after acquiring an additional 7,398 shares during the last quarter. Brasada Capital Management LP grew its position in HCP by 36.6% in the third quarter. Brasada Capital Management LP now owns 42,812 shares of the real estate investment trust’s stock worth $1,525,000 after buying an additional 11,479 shares during the last quarter. Bartlett & Co. LLC acquired a new position in HCP in the third quarter worth approximately $36,000. Tibra Equities Europe Ltd acquired a new position in HCP in the third quarter worth approximately $4,960,000. Finally, Strategic Wealth Advisors Group LLC grew its position in HCP by 4.2% in the third quarter. Strategic Wealth Advisors Group LLC now owns 11,760 shares of the real estate investment trust’s stock worth $420,000 after buying an additional 473 shares during the last quarter. 95.80% of the stock is currently owned by institutional investors and hedge funds.

A number of equities analysts recently commented on the stock. ValuEngine lowered shares of HCP from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Barclays raised their price objective on shares of HCP from $37.00 to $39.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 2nd. KeyCorp raised their price objective on shares of HCP from $34.00 to $37.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 2nd. Argus raised shares of HCP from a “hold” rating to a “buy” rating in a research note on Tuesday, September 10th. Finally, Morgan Stanley raised their price objective on shares of HCP from $32.00 to $35.00 and gave the stock an “equal weight” rating in a research note on Tuesday, September 17th. Two analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. HCP currently has an average rating of “Buy” and a consensus target price of $36.78.

NYSE:HCP traded down $0.89 on Friday, reaching $33.64. The stock had a trading volume of 4,003,528 shares, compared to its average volume of 2,801,829. The company has a market capitalization of $17.57 billion, a P/E ratio of 18.48, a price-to-earnings-growth ratio of 6.81 and a beta of 0.22. HCP, Inc. has a 1-year low of $26.58 and a 1-year high of $37.93. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 1.01. The stock has a fifty day moving average price of $36.24 and a 200-day moving average price of $33.42.

HCP (NYSE:HCP) last announced its earnings results on Wednesday, October 30th. The real estate investment trust reported ($0.09) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.43 by ($0.52). HCP had a return on equity of 12.78% and a net margin of 43.66%. The company had revenue of $538.00 million for the quarter, compared to analyst estimates of $503.65 million. During the same quarter in the previous year, the company posted $0.44 earnings per share. HCP’s revenue for the quarter was up 18.0% on a year-over-year basis. Sell-side analysts predict that HCP, Inc. will post 1.75 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, November 19th. Stockholders of record on Monday, November 4th will be issued a $0.37 dividend. This represents a $1.48 annualized dividend and a dividend yield of 4.40%. The ex-dividend date is Friday, November 1st. HCP’s dividend payout ratio (DPR) is presently 81.32%.

In other news, COO Thomas Klaritch sold 35,014 shares of the company’s stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $36.02, for a total value of $1,261,204.28. Following the completion of the transaction, the chief operating officer now owns 230,529 shares in the company, valued at $8,303,654.58. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.13% of the stock is owned by corporate insiders.

HCP Profile

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

See Also: What is diluted earnings per share (Diluted EPS)?

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.